Company Profile
  News
  Conditions
  Medicines
Boehringer IngelheimBoehringer Ingelheim Prescription Medicine
Boehringer IngelheimBoehringer Ingelheim Non Prescription Medicine
Boehringer IngelheimBoehringer Ingelheim Veterinary Medicine
Boehringer IngelheimBoehringer Ingelheim Companion Animal Products
Boehringer IngelheimBoehringer Ingelheim Canine Osteoarthritis and Acute Pain
Boehringer IngelheimBoehringer Ingelheim Heart Disease
Boehringer IngelheimBoehringer Ingelheim Chronic Skin Disease
Boehringer IngelheimBoehringer Ingelheim Equine Products
Boehringer IngelheimBoehringer Ingelheim Farm Animal Products
  Community Spirit
  Careers
Boehringer Ingelheim
Boehringer Ingelheim UK
Chronic Skin Disease

Chronic Skin Disease

The condition of an animal's coat will often reflect their general health status. While a bright, shiny coat is usually a sign of good health, a dull lifeless coat and scurfy skin can often indicate the first signs that the pet is feeling under the weather, or more commonly indicate primary skin disease.

Allergic skin disease in dogs is a chronic and frequently painful condition not unlike human excema. Whilst steroid treatment may control the itching, in the longer term side-effects are common with these medicines. Nowadays, the treatment of skin disease in dogs is centred around using a combination of treatments in order to minimise the occurrence of side effects in the longer term. Vetmedica provides a coordinated portfolio of canine dermatology products to achieve this goal:

Boehringer Ingelheim has developed a range of non-pharmaceutical products, high in natural essential fatty acids, which are essential in maintaining skin condition and moisture content.Viacutan Plus® (an oral supplement available in both airless-pump and capsule form) and Dermocanis High GLA Shampoo® both contain high concentrations of the essential fatty acids (GLA) which have been demonstrated to aid in the maintenance of normal healthy skin.

Voren Suspension® and Voren 14® provide an alternative when the application of GLA-based products are insufficient to control the discomfort associated with itching. Whilst steroid use is ideally limited in the control of acute dermatitis, both products provide potent and effective tools in the management of acute flare-ups.



Boehringer Ingelheim
Corporate Site


17 May 2008
  Contact us
  How to find us
  Search
  Site map
Boehringer Ingelheim Voted Great Place to Work for Fourth Year Running
 
Boehringer Ingelheim Websites
Boehringer Ingelheim
Large Text
 

Boehringer Ingelheim UK websites:
Corporate: Boehringer Ingelheim UK, Boehringer Ingelheim Corporate Site
Consumer Health Care: Pharmaton, Antistax, Dulcolax, Healthy Legs, IBS Relief, Constipation facts, Pass it On, Dulcoease, 1in4men
Animal Health: Vetmedin, Metacam, Ingelvac Myho, Mamyzin, Seraquin
Access to and use of this website is subject to our Terms of use which users are deemed to accept by accessing this website.
© 2008 Boehringer Ingelheim Ltd UK. All rights reserved. Company Registration Number: 711858 England & Wales
Boehringer Ingelheim Limited, Registered Office, Ellesfield Avenue, Bracknell, Berks RG12 8YS